An ALS compound that's ready for biotech development is described in this Oct. 5, 2009, Webcast
|MDA and the ALS Therapy Development Institute began a jointly funded, $36 million ALS drug development project in 2007.|
A Webcast is now available of the fourth annual research symposium held as part of the ALS TDI Leadership Summit 2009 on Oct. 5. The symposium was conducted at the MDA-supported ALS Therapy Development Institute in Cambridge, Mass.
The Webcast of the symposium, an update on research in ALS, is free but requires registering via the Web site at ALS TDI Leadership Summit 2009.
Among the highlights of the presentation are: